Amarna Therapeutics is biotech company developing a next-generation viral vector platform playing a key role in transforming treatment across many disease areas.
Amarna Therapeutics is biotech company developing a next-generation viral vector platform playing a key role in transforming treatment across many disease areas.
Mymetics is developing preventative vaccines using both virosomes as an effective adjuvant and vaccine delivery method, and an innovative antigen design to generate mucosal antibodies.
Agendia is a leading molecular diagnostics company developing FFPE-based genomic diagnostic products, allowing clinically relevant gene expression profiling for cancer patients.
Dezima Pharma is a biopharma company developing novel drugs to treat dyslipidemia.
Applikon Biotechnology is a world leader in developing advanced bioreactor systems from laboratory scale to production scale.
AM-Pharma is a biopharma company developing a proprietary recombinant human Alkaline Phosphatase (recAP) against Acute Kidney Injury, Inflammatory Bowel Disease and Hypophosphatasia.
ProFibrix is a biotech company specialized in fibrinogen technology to develop innovative products for the hemostasis and regenerative medicine markets.
PamGene is a biotech company specialized in kinase and nuclear receptor assays for personalized medicine and drug discovery.
Mimetas offers the second best cell-based model after humans, using human cells growing in three-dimensional structures. Mimetas combines different cell types, revealing relevant interactions within tissues, and continuously perfused cells with growth medium. Mimetas can also connect multiple organ functions, for example liver and kidney, with its OrganoPlate technology.
eBioscience is a biotech company providing high quality reagents that empower the process of scientific discovery in cellular immunity and oncology, mainly focusing in flow cytometry and immunodetection.